Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
164.35 | -22,09% | -11,8% | 290.220,37 | 3,79% | 7,03% |
|
NasdaqGS:AMGN
Amgen
|
314.72 | -12,88% | -4,16% | 168.826,73 | 2,82% | 5,31% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40.336,01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
230.04 | -15,03% | 0,05% | 33.493,11 | 0% | -10,89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
76.97 | 154,97% | 238,58% | 14.615,05 | 0% | 32,46% |
|
NasdaqGS:INCY
Incyte
|
56.86 | 104,81% | 153,29% | 12.012,93 | 0% | 27,62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
69.06 | 0% | 0% | 8.843,51 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
106.64 | 0% | 0% | 6.783,92 | 0% | 0% |
|
NasdaqGS:EXEL
Exelixis
|
21.23 | 39,15% | 69,39% | 6.338,53 | 0% | -8,84% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6.165,32 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
10.43 | 0% | 0% | 3.763,74 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3.739,11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3.724,47 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
25.00 | 0% | 0% | 3.062,73 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2.986,1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
9.50 | 0% | 0% | 2.807,75 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
39.94 | 0% | 0% | 2.631,15 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
14.85 | 0% | 0% | 2.512,75 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
47.61 | -94,78% | -76,15% | 2.364,47 | 0% | 0% |
|
NasdaqGM:ADMA
ADMA Biologics
|
9.06 | 0% | 0% | 2.042,24 | 0% | 0% |
